Management of Lovenox-Induced Swelling and Lump

Initial Assessment and Management

The American Academy of Otolaryngology-Head and Neck Surgery recommends continuing Lovenox without interruption unless there are other contraindications to anticoagulation, and applying local measures such as cold compresses initially, followed by warm compresses after 24-48 hours to promote resorption, in patients with benign injection site reactions 1
For patients at high risk of thromboembolism, the American College of Cardiology suggests considering switching to unfractionated heparin intravenously rather than stopping anticoagulation entirely, in cases of suspected tissue necrosis 2

The American College of Cardiology recommends not stopping anticoagulation in high-risk patients, including those with mechanical prosthetic heart valves, recent VTE, active cancer with VTE, or atrial fibrillation with high stroke risk (CHA2DS2-VASc ≥4) 2
The Journal of Thrombosis and Haemostasis suggests that patients with recent VTE (within 3 months) or active cancer with VTE are at high risk and should not stop anticoagulation 3

The American Academy of Otolaryngology-Head and Neck Surgery recommends unfractionated heparin as the preferred alternative for acute situations, as it can be rapidly reversed with protamine sulfate if bleeding occurs 1
The American College of Cardiology suggests that warfarin can be initiated for long-term anticoagulation once the acute reaction resolves 2
The Journal of Thrombosis and Haemostasis advises against using DOACs in active cancer patients or those requiring frequent procedural interventions due to lack of rapid reversal agents and drug interactions 3

The American Academy of Otolaryngology-Head and Neck Surgery recommends reassessing the injection site within 24-48 hours to ensure the reaction is not progressing, and expecting gradual resolution over 1-2 weeks with appropriate local care, in patients with benign reactions 1